[ Inside the business ]

DOCS stock analysis

DOCS · Doximity, Inc.

Services-computer programming services. Growing 4%. Keeps 26¢ of every dollar.

Watch: growth that has stopped speeding up.

The future, in 7 questions

Priced in: 3.3× sales in 5 yrs. Evidence: sales +4% · 26¢ profit/$1.

01 What's priced in?3.3× sales in 5 yrs
Sales now$662M
Needed in 5 yrs$2.2B
02 Is the wave rising?No Radar technology matched

Not among the companies mentioning Radar's technologies most.

03 Will customers keep buying?Sales +4%, steady
Customer B 11%Everyone else
Prepaid $100MSales +4%, steady
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Keeps 26¢ per $1, falling
'22'23'24'25'2626¢
Before running costs: 87% → 89%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares −1.6%/yrDebt $0
07 What could break it?1 to watch
  • Growth peaked

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth peaked.

Sales growth +5%, +7%, then +4% vs. a year ago.

What could go wrong

Few warning signs.

It has moved 1.3× the market. In the 2022 rate shock it fell 40% while the market fell 24%. Debt is covered by cash.

Speculative check

Self-funding.

Passes every condition: profitable, cash-generating and financially sound.

What they sell

94% Subscription.

Subscription 94% · Service, Other 6%

Where each dollar goes

26¢ profit.

13¢ to make what it sells, 60¢ on research and overhead, 26¢ left over. Revenue $662M in the last 12 months.

Its market

1.7× the economy.

The government expects its industry, computer systems design and related services, to grow 3.4% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Shake-out.

Its cash flows are mixed, typical of a company in transition.

Earnings quality

Clean.

Its numbers don't resemble those of past manipulators. Cash covers 219¢ of each $1 of profit.

Competitive advantage

7 of 7 years.

Returns beat its 10.3% cost of capital in 7 of the last 7 years. Gross margin went from 87% to 89%.

Future bets

23% on research.

$154M a year on R&D. $0M on equipment and buildings.

All figures from Doximity, Inc.'s SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.